Skip to main content

Table 1 Characteristics of the studied population

From: The potential impact of adding genetic markers to clinical parameters in managing high-risk prostate cancer patients

 

n = 231

Mean (SD 1 ) age (years)

66.9 (7.74)

Stage

 

1

n = 9 (3.90%)

2

n = 140 (60.60%)

3

n = 47 (20.35%)

4

n = 23 (9.96%)

Missing

n = 12 (5.02%)

Gleason score

 

2-6

n =145 (62.77%)

7

n = 43 (18.61%)

8-10

n = 28 (12.12%)

Missing

n = 15 (6.27%)

PSA levels (ng/ml)

 

≤ 4.0

n = 1 (0.42%)

4.1-10

n = 98 (42.42%)

10.1-20

n = 63 (27.27%)

> 20

n = 40 (17.32%)

> 1,000

n = 2 (0.84%)

Missing

n = 27 (11.69%)

  1. n (number of patients), SD (standard deviation).